Cardiac Screening Company, Heart Test Laboratories, Names Richard Gray MD as It's U.S. Clinical Advisor

Colleyville, TX, June 20, 2009 --(PR.com)-- As a cardiologist since 1975, Dr. Richard Gray has focused his career on academic medicine, teaching, research, program development and leadership as well as clinical medicine. Since 2002 Dr. Gray has been the Medical Director of Sutter Pacific Heart Centers at California Pacific Medical Center in San Francisco and Marin General Hospital in Marin County, California. From 1996 to 2002, Dr. Gray was Chief of Cardiology at Regions Hospital of St Paul Minnesota and Director of Cardiovascular Services for Health Partners of Minneapolis- St. Paul, and from 1992 to 1996, Professor and Chairman of the Department of Medicine at the University Of North Dakota School Of Medicine. From 1975 to 1993 he was Staff Associate Cardiologist at Cedars-Sinai Medical Center, Los Angeles, California, serving from 1982 to 1992 as the Director of Surgical Cardiology and from 1988 to 1990 he was the Medical Director of the Heart Transplant program at Cedars Sinai.

Dr. Gray has held appointments as Professor of Medicine at the University of California School of Medicine in Los Angeles, University of Minnesota and at the University Of North Dakota School Of Medicine. He has been principal investigator on many cardiac research studies and has authored numerous peer review publications, abstracts, book chapters and a textbook. Since 1977, Dr. Gray has been involved in numerous medical device development projects involving very early stage and small start-up as well as established corporate level activity. Dr. Gray has been active with the American Heart Association since 1975. In 1991 he served as President of the former Greater Los Angeles Affiliate, and has served in various leadership capacities at the former Dakota Affiliate, Northland Affiliate, and recently, the San Francisco Division Board and is currently the Western States Affiliate President-Elect.

"We are extremely excited about the wealth of experience and knowlege Dr. Gray brings to our team", said Drew Diaz, CEO of Heart Test Labs." His long history of being on the cutting edge of cardiac care makes him extremely valuable in the continuing development of our non-invasive Myo-Vista(TM) cardiac screening system."

Heart Test Laboratories Inc. (HTL), a US based company is a rapidly developing medical technology company concentrating on inventing life saving devices for the Coronary Arterial Disease (CAD) market. Heart Test Laboratories is in the final stages of releasing it's new patent pending screening device, the MyoVista™, a portable, inexpensive, diagnostic test used to determine the presence and level of Myocardial Ischemia, a restriction of blood flow to the heart, which is a contributing factor in 67% of all Coronary Arterial Disease.

###